DSpace

DSpace at RU >    University Library >    Academic bibliography >

SFX Query

Files in This Item:

File Description SizeFormat
publisher's version304.54 kBAdobe PDFUnder Embargo

Title: Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
Author(s): Luin, M. van (314325905)
Ende, M.E. van der
Richter, C.
Visser, M. de
Faraj, D.
Ven, A.J.A.M. van der (142704113)
Gelinck, L.
Kroon, F.
Wit, F.W.
Schaik, R.H. van
Kuks, P.F.M.
Burger, D.M. (119962306)
Publication year: 2010
Document type: Article / Letter to editor
Journal: AIDS
ISSN: 0269-9370
Volume: vol. 24
Issue: iss. 8
Start page: p. 1223
End page: p. 1226
Abstract: HIV-infected travellers frequently use atovaquone/proguanil as malaria prophylaxis. We compared atovaquone/proguanil pharmacokinetics between healthy volunteers and HIV-infected patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. The geometric mean ratio (95% confidence interval) area under the curve (AUC)0-->t for atovaquone relative to the healthy volunteers was 0.25 (0.16-0.38), 0.26 (0.17-0.41) and 0.54 (0.35-0.83) for patients on efavirenz, lopinavir/ritonavir and atazanavir/ritonavir, respectively. Proguanil plasma concentrations were also significantly lower (38-43%). Physicians should be alert for atovaquone/proguanil prophylaxis failures in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.
Subject: N4i 2: Invasive mycoses and compromised host
N4i 3: Poverty-related infectious diseases
NCEBP 13: Infectious diseases and international health
Subject: NCEBP 13: Infectious diseases and international health
Organization: Clinical Pharmacy
UMCN Extern
General Internal Medicine
Appears in Collections:Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/87324

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback